WENDIE MALKINSKI: Open Payments
NPI 1922216480 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 39 payments from 10 companies in 2025. Trend: 2023 $454 · 2024 $769 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $165 |
| Axsome Therapeutics, Inc. | 6 | $113 |
| Lundbeck LLC | 4 | $92 |
| Tris Pharma Inc | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Alkermes, Inc. | 1 | $26 |
Products named: VRAYLAR, REXULTI, Dyanavel XR, Auvelity, CAPLYTA, Sunosi, Jornay PM, Qelbree.
Industry payments across MD — which companies pay providers there.
